rheum Conference-Coverage

Conference Coverage

Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial

12/12/2023

Priyam Vora, Associate Editor

The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.

The phase 3 SELECT-EARLY trial...

12/12/2023

Rheumatology & Arthritis

Conference Coverage

JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study

12/05/2023

Priyam Vora, Associate Editor

JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?

JAK inhibitors (JAKi) have been...

12/05/2023

Rheumatology & Arthritis

Conference Coverage

PsA and PsO Affecting Work Productivity?

11/20/2023

Priyam Vora, Associate Editor

Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.

Dr Nancy Shadick explains the...

11/20/2023

Rheumatology & Arthritis

Conference Coverage

Paras Karmacharya, MD, on Identifying Distinct Phenotypes in PsA

11/15/2023

Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.

Dr Paras Karmacharya discusses...

11/15/2023

Autoimmune

Conference Coverage

Impact of Social Determinants of Health on Chronic Conditions

11/13/2023

Priyam Vora, Associate Editor

Research presented at ACR Convergence assessed the impact of social determinants of health on patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.

Research presented at ACR...

11/13/2023

Rheumatology & Arthritis

Conference Coverage

Discrepancies Between Patients' and Physicians' Global Assessments in PsA

11/13/2023

Priyam Vora, Associate Editor

Dr Proton Rahman identified factors driving disagreement between patients and physicians analyzing the data from more than 1000 participants.

Dr Proton Rahman identified...

11/13/2023

Rheumatology & Arthritis

Conference Coverage

Treatment Persistence Differs Between Men and Women with PsA

11/13/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

A study conducted in France revealed significant differences in how strongly the sexes adhered to therapies for psoriatic arthritis.

A study conducted in France...

11/13/2023

Rheumatology & Arthritis

Conference Coverage

Clinical-Genetic Risk Score Developed for ILD Among Patients With RA

11/12/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

A new combined clinical-genetic risk score has demonstrated superiority to clinical risk factors alone for diagnosing interstitial lung disease (ILD) among patients with rheumatoid arthritis (RA).

A new combined clinical-genetic...

11/12/2023

Rheumatology & Arthritis

Conference Coverage

The Role of Biologics in CV Risk Regulation in Rheumatoid Arthritis

11/12/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

Dr George Karpouzas explained how biologic therapies may protect against major cardiovascular events among patients with rheumatoid arthritis.

Dr George Karpouzas explained...

11/12/2023

Rheumatology & Arthritis

Conference Coverage

Refractory Rheumatoid Arthritis: 2 Decades of Data Show Need for More Research

11/12/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...

Dr Kristin Wipfler reviews data from the FORWARD biobank on the need for more research into the refractory phenotype of rheumatoid arthritis.

Dr Kristin Wipfler reviews data...

11/12/2023

Rheumatology & Arthritis

Conference Coverage

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products